P-15 Peptide Bone Graft Achieves Spine Fusion Nearly Twice as Fast as Autograft | Research

The takeaway

P-15L peptide bone graft was statistically superior to autograft for time-to-fusion in spinal surgery (HR 1.87), with 57.6% vs 26.9% fusion at 6 months and 81.1% vs 54.9% at 24 months.

Nearly 2× faster fusion
P-15L peptide graft achieved spinal fusion at nearly double the rate of patient's own bone, with 57.6% fused at 6 months vs only 26.9%

What the researchers found

P-15L superior time-to-fusion: HR 1.87 (95% CI 1.47-2.38, p<0.0001). Fusion rates: 6mo 57.6% vs 26.9%; 12mo 68.8% vs 41.5%; 24mo 81.1% vs 54.9%. ~59% had pseudoarthrosis risk factors. Both groups improved in VAS and SF-12.

Why it matters

Faster fusion means faster recovery, less pain, and earlier return to normal activity for spine surgery patients.

How the study worked

Pre-specified secondary analysis of the P-15L pivotal 290-patient multicenter RCT, with Kaplan-Meier time-to-fusion analysis, VAS pain scores, and SF-12 quality of life at 24 months.

What this study cannot tell us

Same pivotal trial limitations. Time-to-fusion CT assessment has inherent variability. Single-blind design.

How to read the evidence

Level I evidence from pivotal multicenter RCT with pre-specified time-to-fusion analysis.

When this study was published

Published in 2025.

The bigger picture

P-15 peptide technology represents the most successful clinical application of a synthetic peptide in orthopedic surgery.

Questions still open

Does faster fusion translate to faster return to work?
Would P-15L benefit patients with multiple-level fusion?
Can the P-15L platform be adapted for other bone repair applications?

Common questions

How much faster does P-15L heal spine fusion?

Nearly twice as fast. At 6 months, 58% of P-15L patients had complete fusion vs only 27% with standard bone graft. The peptide accelerates bone cell growth and healing.

Does faster fusion mean less pain?

Both groups improved in pain scores, and the study was not designed to compare pain timelines specifically. However, faster fusion generally correlates with faster recovery.

Read the original research

P-15 Peptide Enhanced Bone Graft Improves Time to Fusion in Transforaminal Lumbar Interbody Fusion: A Randomized, Controlled, Investigational Device Exemption Study.

Spine, 51(4), 229-237

View on PubMed ↗Publisher’s paper ↗

Citation

Harrop, James S; Steinmetz, Michael P; O'Toole, John E; Chaput, Christopher D; Sasso, Rick C; Strenge, K Brandon; Maislin, Greg; Mullin, Jeffrey P; Freeman, Thomas B; Guanciale, Anthony; Lantner, Howard; Janssen, Michael E; Schwartz, David G; Small, John M; Hsu, Wellington K; Arnold, Paul M. (2026). P-15 Peptide Enhanced Bone Graft Improves Time to Fusion in Transforaminal Lumbar Interbody Fusion: A Randomized, Controlled, Investigational Device Exemption Study.. Spine, 51(4), 229-237. https://doi.org/10.1097/BRS.0000000000005580